Company News
-
November 28, 2024
With E-Resale, bioMérieux innovates by giving a second life to its instruments
Launched last July, starting with Africa and Middle East, the E-Resale platform allows to purchase and sell second-hand bioMérieux instruments for clinical applications. This is an innovative offer in the field of circular economy and a first on the in vitro diagnostics market. -
November 22, 2024
bioMérieux and St James’s Hospital in Ireland announce the world-first Data & IT Centre of Reference partnership
On November 14th, 2024, bioMérieux officially launched its first Data & IT Centre of Reference partnership with St James's Hospital in Dublin, Ireland. This landmark collaboration has been celebrated with an event held at the Davis Coakley Lecture Theatre, St James's Hospital. -
November 21, 2024
A 100% digital campaign to raise awareness about antimicrobial resistance
Globally, it was estimated that approximately 4.95 million people died from Antimicrobial Resistance-related causes in 20191. And yet, one in three adults doesn’t understand what this term means2. Faced with this alarming situation, an awareness-raising campaign encourages the general public to change their behaviour with regard to the use of antibiotics. Indeed, each person, at their own level, has a role to play to preserve their effectiveness. -
November 13, 2024
bioMérieux signed an Agreement to acquire Neoprospecta
bioMérieux, a world leader in the field of in vitro diagnostics, signed in November 2024 a Sale and Purchase Agreement (SPA) to acquire Neoprospecta. This company, based in Florianopolis, Brazil, develops and markets innovative user-friendly data and genomics solutions for augmenting quality assurance programs and improve microbiological risk prevention in food and pharma industries. -
October 10, 2024
Advancing the Global AMR Agenda: A Call for Multi-Sector Collaboration
During the 2024 United Nations United Nations High-Level Meeting on Antimicrobial Resistance (AMR), a multisectoral event titled "Advancing Together: Securing the Global AMR Agenda by Harnessing the Collective Strength of Multi-Sector Partnerships" took place on September 24 in New York. bioMérieux, in partnership with The Wellcome Trust, The American Society of Microbiology, Malawi, and the French Republic, organized the event to focus on fostering a collaborative ecosystem that establishes sustainable solutions across the entire AMR landscape. From diagnosis and treatment to surveillance and action plans, this initiative spanned human health, animals, and the environment.
Follow us on Socials for more news!